首页> 外文期刊>Journal of Drug Delivery and Therapeutics >FORMULATION AND EVALUATION OF EFFERVECENT FLOATING TABLETS OF ANTIDIABETIC DRUG
【24h】

FORMULATION AND EVALUATION OF EFFERVECENT FLOATING TABLETS OF ANTIDIABETIC DRUG

机译:消泡药泡腾片的配方与评价

获取原文
           

摘要

The aim present investigation is Formulation and Evaluation of Effervescent Floating Tablets of antidiabetic drug. Gastric retention are such systems, which increase the gastric retention time of the dosage forms at the stomach and upper part of the small intestine and suitable for the drug having site-specific absorption from the above sites. The Metformin HCl an orally administered biguanide of BCS class-3 High solubility and low permeability, which is widely use in the management of and the type-II diabetes, is an oral anti- hyperglycemic agent, shows incomplete absorption from the gastrointestinal tract and from the gastrointestinal track and absolute bioavailability is 50-60%with relatively short plasma half-life of 1.5-4.5 hours. It was using different polymers studying of deferent factors affecting the floating behavior of the prepare tablets was of our goals and important target in this part. Gastro-retentive tablets of Metformin HCl were prepared by wet granulation method using HPMC K200M (Hydroxylpropyl methyl cellulose) micro crystalline cellulose PH 101, sodium bicarbonate, HPMC K100 (LV), Magnesium stearate, colloidal silicon dioxide. In this formulation HPMC K 200 M was using different concentration. The Gastro-retentive tablet of Metformin HCl was evaluation of compression blend Angle of repose, Bulk density, tapped density, Drug compressibility study, Drug release rate, floating lag time etc. Result of our present study suggests that gastro-retentive tablets of Metformin HCl can be successfully designed to develop sustained release drug delivery which can reduce dosing frequency. Keywords: Effervescent system, gas generating system, gastro retentive drug delivery system, sustained drug release, Metformin hydrochloride
机译:目前的研究目的是抗糖尿病药泡腾片的研制与评价。胃retention留是这样的系统,其增加了剂型在胃和小肠上部的胃the留时间,并且适合于从上述部位具有部位特异性吸收的药物。盐酸二甲双胍是BCS 3类口服双胍类药物高溶解度和低渗透性已被广泛用于II型糖尿病的治疗,它是一种口服降糖药,从胃肠道和肠胃道吸收不完全。胃肠道和绝对生物利用度为50-60%,血浆半衰期相对较短,为1.5-4.5小时。它正在使用不同的聚合物研究影响制剂片剂漂浮行为的不同因素,这是我们的目标和重要目标。通过湿法制粒法,使用HPMC K200M(羟丙基甲基纤维素)微晶纤维素PH 101,碳酸氢钠,HPMC K100(LV),硬脂酸镁,胶体二氧化硅,制得盐酸二甲双胍胃滞留片。在此配方中,HPMC K 200 M使用不同的浓度。盐酸二甲双胍胃滞留片评价了休克混合角,休克密度,堆积密度,堆积密度,药物可压缩性研究,药物释放速率,漂浮滞后时间等。我们的研究结果表明,盐酸二甲双胍胃滞留片可以成功设计出可以降低给药频率的持续释放药物。关键词:泡腾系统气体发生系统胃滞留药物输送系统持续释放盐酸二甲双胍

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号